Carregant...

Breaking barriers to novel analgesic drug development

Acute and chronic pain complaints, while very common, are generally poorly served by existing therapies. The unmet clinical need reflects the failure in developing novel classes of analgesics with superior efficacy, diminished adverse effects and a lower abuse liability than those currently availabl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Rev Drug Discov
Autors principals: Yekkirala, Ajay S, Roberson, David P, Bean, Bruce P., Woolf, Clifford J.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5675565/
https://ncbi.nlm.nih.gov/pubmed/28596533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd.2017.87
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!